Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness. Lindenberg M, Retel V, Rohaan M, van den Berg J, et al. BMC Cancer 2020;20:712.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lindenberg M, Retel V, Rohaan M, van den Berg J, et al. Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness. BMC Cancer 2020;20:712.
PMID: 32736535